Website and Blog for the Sam McMahon Trust

A comprehensive article published in Dove Press Journal: Neuropsychiatric Disease and Treatment examines the current and emerging treatment options for the management of  Friedreich’s Ataxia. Many current approaches are reviewed and possible future treatments are documented. The article does conclude that available evidence suggests that those with FA should be treated with Idebenone but that further clincial trials are needed. To read the article click here.

If you are ordering Idebenone from Kirkman Labs in the United States then it’s worth your while registering to become part of the ‘Kirkman Family‘ on the home page of their site. They will email their newsletter to you every month and it contains a code which will give you a discount off their products. The most recent offer gave 15% off orders over $100. You can check out the Kirkman Labs site here.

You should always seek medical advice before embarking on a course of treatment.